Kinetics of acetyl coenzyme A: Arylamine N-acetyltransferase from rapid and slow acetylator frog tissues

Drug Metabolism and Disposition

Volumn 24, Issue 2, 1996, Pages 137-141

  Ho, Chin C ^a   Lin, Tsae H ^a   Lai, Yih S ^a   Chung, Jing G ^a,c   Levy, Gerald N ^b   Weber, Wendell W ^b  

^a China Medical College

^b UNIVERSITY OF MICHIGAN   (United States)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

2 FLUORENYLAMINE; 4 AMINOBENZOIC ACID; ACYLTRANSFERASE; ARYLAMINE ACETYLTRANSFERASE;

ACETYLATION; ACETYLATOR PHENOTYPE; ANIMAL TISSUE; ARTICLE; BLADDER; BLOOD; COLON; FEMALE; FROG; LIVER; MALE; MICHAELIS CONSTANT; NONHUMAN; PRIORITY JOURNAL;

ACETYL COENZYME A; ACETYLATION; ANIMALS; ARYLAMINE N-ACETYLTRANSFERASE; COLON; FEMALE; KINETICS; LIVER; MALE; PHENOTYPE; RANIDAE; URINARY BLADDER;

EID: 0030020877     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. H. H. Andres, H. J. Kolb, and L. Weiss: Purification and physical-chemical properties of acetyl-CoA:arylamine N-acetyltransferase from pigeon liver. Biochim. Biophys. Acta 746, 182-192 (1983).
2. T. Deguchi, Y. Sakamoto, Y. Sasaki, and K. Uyemura: Arylamine N-acetyltransferase from chicken liver. I. Monoclonal antibodies, immunoaffinity purification, and amino acid sequences. J. Biol. Chem. 263, 7528-7533 (1988).
3. W. W. Weber: "The Acetylator Genes and Drug Response." Oxford University Press, New York, 1987.
4. S slow acetylator congenic mice. Drug Memb. Dispos. 21, 1057-1063 (1993).
5. M. J. Rieder, N. H. Shear, A. Kanee, B. K. Tang, and S. P. Spielberg: Prominence of slow acetylator phenotype among patients with sulfonamide hypersensitiviry reactions. Clin. Pharmacol. Ther. 49, 13-17 (1991).
6. R. A. Cartwright, R. W. Glasham, H. J. Rogers, R. A. Ahmed, D. Barham-Hall, E. Higgens, and M. A. Kahn: Role of N-acetyltransferase phenotype in bladder carcinogenesis: a pharmacogenetic epidemiological approach to bladder cancer. Lancer 2, 842-846 (1982).
7. N. P. Lang, D. Z. J. Chu, C. F. Hunter, D. C. Kendall, T. J. Flammang, and F. F. Kadlubar: Role of aromatic amine acetyltransferase in human colorectal cancer. Arch. Surg. 121, 1259-1261 (1986).
8. K. F Hett, B. M. David, P. Detchon, W M. Castledon, and R. Kwa: Acetylator phenotype in colorectal carcinoma. Cancer Res. 47, 1466-1469 (1987).
9. W. W. Weber, J. Micelli, D. J. Hearse, and S. Drummond: N-acetylation of drugs. Pharmacogenetic studies in rabbits selected for their acetylator characteristics. Drug Metab. Dispos. 4, 94-101 (1976).
10. D. R. Juberg, J. T. Bond, and W. W. Weber: N-acetylation of aromatic amines: genetic polymorphism in inbred rat strains. Pharmacogenetics 1, 50-57 (1991).
11. D. W. Hein, J. G. Omichinski, J. A. Brewer, and W. W. Weber: A unique pharmacogenetic expression of the N-acetylation polymorphism in the inbred hamster. J. Pharmacol. Exp. Ther. 220, 8-15 (1982).
12. G. N. Levy, K. J. Martell, J. H. DeLeon, and W. W. Weber: Metabolic, molecular genetic, and toxicological aspects of the acetylation polymorphism in inbred mice. Pharmacogenetics 2, 197-206 (1992).
13. S. S. Mattano, R. P. Erickson, M. N. Nesbitt, and W. W. Weber: Linkage of Nat and Es-1 in the mouse and development of strains congenic for N-acetyltransferase. J. Heredity 79, 430-433 (1988).
14. D. W. Hein: A new model for risk assessments: construction of homozygous rapid and slow acetylator congenic inbred Syrian hamster lines. Toxicol. Methods 1, 44-52 (1991).
15. M. Blum, D. M. Grant, A. Demierre, and U. A. Meyer: N-Acetylation pharmacogenetics: a gene deletion causes absence of arylamine N-acetyltransferase in livers of slow acetylator rabbits. Proc. Natl. Acad. Sci. U.S.A. 86, 9554-9557 (1989).
16. D. W. Hein, W. G Kirlin, R. J. Ferguson, and W. W. Weber: Biochemical investigation of the basis for the genetic N-aceytylation polymorphism in the inbred hamster. J. Pharmacol. Exp. Ther. 234, 358-364 (1985).
17. M. Blum, D. M. Grant, O. W. McBride, M. Heim, and U. A. Meyer Human arylamine N-acetyltransferase genes: isolation, characterization, chromosomal localization, and functional expression. DNA Cell Biol. 9, 193-203 (1990).
18. S. L. Kelly and E. Sim: Arylamine N-acetyltransferase in Balb/c mice: identification of a novel mouse isozyme by cloning and expression in vitro. Biochem. J. 302, 347-353 (1994).
19. K. P. Vatsis and W. W. Weber: The old/new genetics and human acetylator polymorphisms. Pharmacogenetics in press, 1996.
20. K. P. Vatsis and W. W. Weber: Structural heterogeneity of caucasian N-acetyltransferase at the NAT1 gene locus. Arch. Biochem. Biophys. 301, 71-76 (1993).
21. G. N. Levy and W. W. Weber: 2-Aminofluorene-DNA adducts in mouse urinary bladder: effect of age, sex, and acerylator phenotype. Carcinogenesis 13, 159-164 (1992).
22. P. V. Nerurkar, H. A. J. Schut, L. M. Anderson, C. W. Riggs, E G. Snyderwine, S. S. Thorgiersson, W. W. Weber, J. M. Rice, and G. N. Levy: DNA adducts of 2-amino-3-imidazo[4,5-f]quinoline (IQ) in bladder, colon, and kidney of congenic mice differing in Ah-responsiveness and N-acetyltransferase genotype. Cancer Res. 55, 3043-3049 (1995).
23. S. S. Mattano and W. W. Weber: Kinetics of arylamine N-acetyltransferase in tissues from rapid and slow acetylator mice. Carcinogenesis 8, 133-137 (1987).
24. H. H. Andres, A. J. Klem, S. M. Szabo, and W. W. Weber: New spectrophotometric and radiochemical assays for acetyl CoA-arylamine N-acetyltransferase applicable to a variety of arylamines. Anal. Biochem. 145, 367-375 (1985).
25. K. J. Martell, G. N. Levy, and W. W. Weber: Cloned mouse N-acetyl-transferase enzymatic properties of expressed Nat-1 and Nat-2 gene products. Mol. Pharmacol. 42, 265-272 (1992).
26. M. M. Bradford: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254 (1976).
27. W. W. Cleland: The statistical analysis of enzyme kinetics data. Adv. Enzymol. 29, 1-32 (1967).